Value-Based Contracting
Expert articles and analysis related to value-based contracting.
AI Summary — Last 30 Days
CMS’s latest ACO REACH results strengthen the case for keeping or replacing advanced two-sided-risk population models: the soon-to-sunset model generated $988 million in Medicare savings in 2024, while participants such as agilon reported material gross savings and Medicare Trust Fund savings, sharpening the tension between model termination and the Trump administration’s broader push to expand accountable care (ACO REACH savings). At the same time, CMS is positioning MSSP and new pathways such as LEAD as the main vehicles for Medicare VBC scale, with organizations now weighing LEAD versus MSSP participation amid unresolved financial methodology details, while proposed physician payment reforms would phase out MIPS and further steer clinicians toward ACO participation (LEAD risk mitigation). For health systems, ACOs, and payers, the strategic priority is shifting from “whether to enter risk” to portfolio design—choosing between MSSP, LEAD, successor ACO REACH-like models, bundled payment extensions such as CJR-X, and MA risk-adjustment exposure as CMS tightens expectations around savings, coding accuracy, governance, and downside-risk readiness.
Related Articles
How TPMG Cracked the Value-Based Care Code
For independent practices, the financial math of value-based care is challenging. Discover how TPMG cracked the code over their 12-year journey. By maximizing their EHR and through smart organizationa...
Rural, independent Kansas hospitals launch clinically integrated network
Rural, independent Kansas hospitals launch clinically integrated network Fierce Healthcare
Considerations For Integrating Chronic Condition Episodes Into Value-Based Payment Models
Considerations For Integrating Chronic Condition Episodes Into Value-Based Payment Models Health Affairs
7 rural Kansas hospitals form clinically integrated network
7 rural Kansas hospitals form clinically integrated network Becker's Hospital Review
Rural hospital alliances grow as value-based care efforts expand
Rural hospital alliances grow as value-based care efforts expand Modern Healthcare
CMS Could Make Drug Price Negotiations Permanent
CMS Could Make Drug Price Negotiations Permanent - What it Means for Pharma Pharmaceutical Commerce
The 340B Drug Pricing Program at a Crossroads
The 340B Drug Pricing Program at a Crossroads JAMA
How TPMG Cracked the Value-Based Care Code
How TPMG Cracked the Value-Based Care Code Healthcare IT Today
Colorado wins FDA approval to import prescription drugs from Canada
Colorado wins FDA approval to import prescription drugs from Canada Becker's Hospital Review
The IRA Fixed One Medicare Part D Distortion—But Patients Now Face New Tradeoffs
By Bryce Platt, PharmD For years, Medicare Part D plans often preferred high-list/high-rebate branded multiple sclerosis (MS) drugs over lower-cost generics. That was rational behavior inside an irra...